SWI/SNF chromatin remodelers in prostate cancer progression
Frontiers in Epigenetics and Epigenomics · 04.01.2024 · 1
DOI: 10.3389/freae.2023.1337345 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Epigenetics and Epigenomics, online erschienen am 04.01.2024. Verfasst von Sandra C Ordonez-Rubiano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, United States. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Prostate cancer (PCa) is the most commonly diagnosed cancer and the second most common cause of cancer-related deaths in men in the US. The majority of PCa cases arise in the luminal cells of the prostate and develop into adenocarcinoma. Primary PCas are heterogeneous and have alterations in a variety of tumor suppressors and oncogenes; however, the vast majority are dependent on gene expression regulation by androgen receptor (AR), making it the focus for most targeted therapy development. As the incidence of PCa cases resistant to AR-targeted therapies rises, there is renewed attention on how additional genetic and epigenetic alterations contribute to PCa progression and resistance. In this review we summarize the efforts made over the past 20 years to dissect the function of the SWI/SNF chromatin remodelers in PCa. We mainly focus on how SWI/SNF complexes regulate different aspects of AR signaling, facilitate other key drivers in PCa, promote the advancement of the disease, and regulate the tumor microenvironment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN, United States.
- Interdisciplinary Life Sciences-PULSe, Purdue University, West Lafayette, IN, United States.
- Purdue Institute for Cancer Research, Purdue University, West Lafayette, IN, United States.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Ordonez-Rubiano, S. C., Strohmier, B. P., Sood, S., & Dykhuizen, E. C. (2024). SWI/SNF chromatin remodelers in prostate cancer progression. Frontiers in Epigenetics and Epigenomics, 1. https://doi.org/10.3389/freae.2023.1337345
Vancouver
Ordonez-Rubiano SC, Strohmier BP, Sood S, Dykhuizen EC. SWI/SNF chromatin remodelers in prostate cancer progression. Frontiers in Epigenetics and Epigenomics. 2024;1. doi:10.3389/freae.2023.1337345
BibTeX
@article{OrdonezRubiano2024,
author = {Ordonez-Rubiano, Sandra C and Strohmier, Brayden P and Sood, Surbhi and Dykhuizen, Emily C},
title = {SWI/SNF chromatin remodelers in prostate cancer progression},
journal = {Frontiers in Epigenetics and Epigenomics},
year = {2024},
volume = {1},
doi = {10.3389/freae.2023.1337345}
}
EUVIMED